These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4430585)

  • 21. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock.
    Malay MB; Ashton JL; Dahl K; Savage EB; Burchell SA; Ashton RC; Sciacca RR; Oliver JA; Landry DW
    Crit Care Med; 2004 Jun; 32(6):1327-31. PubMed ID: 15187515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional vascular effects of vasopressin: plasma levels and circulatory responses.
    Schmid PG; Abboud FM; Wendling MG; Ramberg ES; Mark AL; Heistad DD; Eckstein JW
    Am J Physiol; 1974 Nov; 227(5):998-1004. PubMed ID: 4440765
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effect of vasopressin infusions on the mesenteric arteries of different species.
    Ring EJ; Oleaga JA; Freiman DB; Dann RW; Baum S
    Invest Radiol; 1978; 13(2):138-42. PubMed ID: 96042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular actions of vasopressin.
    Nakano J
    Jpn Circ J; 1973 Apr; 37(4):363-81. PubMed ID: 4580582
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effect of nitroglycerin and nitroprusside on vasopressin-induced cardiac dysfunction in the dog.
    Zito RA; Diez AR; Groszmann RJ
    J Cardiovasc Pharmacol; 1983; 5(4):586-91. PubMed ID: 6193355
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic effects of superior mesenteric arterial and intravenous vasopressin infusions in patients with portal hypertension.
    Kaufman SL; Maddrey WC; Harrington DP; White RI
    Invest Radiol; 1977; 12(3):210-4. PubMed ID: 863624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses to exogenous dibutyryl adenosine 3',5'-monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs.
    Nozaki H; Okuaki A
    Tohoku J Exp Med; 1975 Feb; 115(2):145-54. PubMed ID: 165589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of vasopressin on portal hypertension following hepatectomy.
    Sirinek KR; Thomford NR
    Surg Gynecol Obstet; 1974 Oct; 139(4):573-7. PubMed ID: 4419573
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of acetaldehyde on the systemic, pulmonary, and regional circulations.
    McCloy RB; Prancan AV; Nakano J
    Cardiovasc Res; 1974 Mar; 8(2):216-26. PubMed ID: 4822795
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effects of norepinephrine and vasopressin on internal thoracic arterial graft flow after off-pump coronary artery bypass grafting.
    Park SY; Kim DH; Kim JS; Lim SH; Hong YW
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):151-4. PubMed ID: 20434175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous versus superior mesenteric artery vasopressin infusions for the treatment of variceal bleeding.
    Burgener FA; Gutierrez OH
    Radiology; 1982 Mar; 142(3):769-72. PubMed ID: 6977790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms of impaired cardiac function by vasopressin.
    Wilson MF; Brackett DJ; Archer LT; Hinshaw LB
    Ann Surg; 1980 Apr; 191(4):494-500. PubMed ID: 7369815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic responses to glycols and to hemolysis.
    MacCannell K
    Can J Physiol Pharmacol; 1969 Jun; 47(6):563-9. PubMed ID: 5797397
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological vs. mechanical reduction in portal pressure: a comparative study.
    Groszmann RJ; Blei AT; Storer EH; Conn HO
    Surgery; 1978 Nov; 84(5):679-85. PubMed ID: 715683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasopressin and hepatic artery. Effect of selective celiac infusion of vasopressin on the hepatic artery flow.
    Barr JW; Lakin RC; Rösch J
    Invest Radiol; 1975; 10(3):200-5. PubMed ID: 1079520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.
    Heyndrickx GR; Boettcher DH; Vatner SF
    Am J Physiol; 1976 Nov; 231(5 Pt. 1):1579-87. PubMed ID: 998804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of vasopressin. Can large doses be safely given?
    Gaskill HV; Sirinek KR; Levine BA
    Arch Surg; 1983 Apr; 118(4):434-7. PubMed ID: 6830433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.